Current and emerging systemic treatment strategies for psoriasis

Philip M Laws, Helen S Young

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Psoriasis is a common chronic inflammatory disease of the skin that has a significant impact on quality of life. A small number of systemic therapies are well established in psoriasis management. These have immunosuppressive and/or anti-proliferative effects on the skin and immune system. As understanding of the pathogenesis of psoriasis has advanced over the last 2 decades, there has been clearer appreciation of the genetic, cellular and immunological components of disease expression, which has provided new insight into potential therapeutic targets, including the development of biological therapies. Biologics offer a unique opportunity to block or inhibit specific key components of psoriasis pathogenesis. The introduction of tumour necrosis factor (TNF).α and interleukin (IL)-12/-23 inhibitors has resulted in remarkable clinical responses in patients with severe psoriasis and has led to the development of a range of other cytokine modulators currently undergoing investigation. More recently, research in keratinocyte biology and immune cell function, particularly intracellular signalling, has afforded additional opportunities to develop a range of small-molecule oral preparations that may prove effective in disease control. This paper reviews current and emerging systemic treatments in the management of psoriasis.

    Original languageEnglish
    Pages (from-to)1867-80
    Number of pages14
    JournalDrugs
    Volume72
    Issue number14
    DOIs
    Publication statusPublished - 1 Oct 2012

    Keywords

    • Antibodies, Monoclonal/therapeutic use
    • Biological Products/therapeutic use
    • Biological Therapy/methods
    • Cytokines/therapeutic use
    • Humans
    • Immune System/drug effects
    • Immunosuppressive Agents/therapeutic use
    • Interleukins/antagonists & inhibitors
    • Keratinocytes
    • Psoriasis/drug therapy
    • Quality of Life
    • Tumor Necrosis Factor-alpha/antagonists & inhibitors

    Fingerprint

    Dive into the research topics of 'Current and emerging systemic treatment strategies for psoriasis'. Together they form a unique fingerprint.

    Cite this